← Evidence map

ArticleBlood advances2023

Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation.

Michael Scordo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2023
2024
2025
2026
this papercites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 36409612